Skip to content
Celexo Exo Cica
Professional Bio-Regenerative Care for Compromised and Reactive Skin
In today’s advancing aesthetic landscape, managing compromised skin barriers and inflammatory conditions requires more than surface-level intervention. ABio materials Co., headquartered in Korea, has developed Celexo Exo Cica a bio-regenerative formulation that combines plant-derived exosome signaling with standardized Centella Asiatica bioactives to support skin health at the cellular level. Exclusively developed for use by licensed medical professionals, this US FDA-listed product reflects the company’s commitment to translating biotechnology into real-world clinical applications. This page explores the science, benefits, and clinical relevance of Celexo Exo Cica.
About ABio materials and Celexo Exo Cica
ABio materials Co. is a biotechnology-driven manufacturer specializing in advanced biomaterials for medical aesthetics, dermatology, and tissue regeneration. Operating pharmaceutical-grade facilities in Korea under ISO 13485 and GMP standards, the company transforms research into clinical-grade products that deliver measurable results. All products are US FDA listed, with ABio materials USA Inc. serving as the exclusive importer and distributor throughout North America.
Celexo Exo Cica addresses inflammatory skin conditions, post-procedural sensitivity, and impaired barrier function through exosome-mediated cellular signaling. The formulation contains plant-derived exosomes at concentrations reaching 5 billion particles per milliliter, combined with Centella Asiatica extract in a 4:1 ratio. The delivery matrix maintains physiological pH between 5.0 and 6.0, formulated specifically for compromised and reactive skin states.
Core Values: Science First formulations grounded in peer-reviewed research and cellular biology. Professional Integrity serving only licensed professionals. Sustainable Innovation environmentally responsible manufacturing practices.
The Science Behind
Celexo Exo Cica
Celexo Exo Cica operates through validated biological mechanisms to restore compromised skin function and support tissue repair.
Exosome-Mediated Communication:
Plant-derived extracellular vesicles deliver bioactive cargo, including growth factors and signaling proteins, directly to target cells, activating repair pathways for enhanced cell survival and controlled inflammatory response.
Anti-Inflammatory Action:
The formulation reduces pro-inflammatory cytokines while increasing anti-inflammatory mediators. Centella bioactives inhibit inflammatory enzymes, producing a measurable reduction in redness and irritation within 24 to 48 hours.
Barrier Restoration:
Active components stimulate expression of barrier proteins, including filaggrin and involucrin, while enhancing ceramide production, measurably reducing water loss by 30 to 50 percent within 72 hours.
Matrix Support:
The formulation activates fibroblast activity, increases collagen expression, and supports appropriate tissue remodeling for improved skin structure and resilience.
Key Benefits of Using Celexo Exo Cica
Supports Natural Regeneration:
Reduces inflammatory markers through cellular pathway modulation with a measurable calming effect within hours of application.
Enhances Other Procedures:
Amplifies results of microneedling, RF, laser, and PRP therapies while reducing expected downtime by 30 to 40 percent.
Safe and Biocompatible:
Formulated specifically for compromised, reactive, and post-procedural skin with minimal irritation potential, validated through clinical testing.
Evidence-Based Formulation:
Based on published research in exosome biology and Centella pharmacology, manufactured under pharmaceutical-grade standards.
Minimal Downtime:
Supports rapid re-epithelialization and barrier restoration, helping patients return to normal activities faster.
Quality Manufacturing:
Produced under ISO 13485 and GMP standards with US FDA listing, complete batch documentation, and stability verification.
Clinical Applications of Celexo Exo Cica
Celexo Exo Cica is used by professionals in various clinical contexts requiring inflammation management and barrier support.
Common Use Cases:
Post-microneedling support at depths between 0.5 and 2.5mm
Adjunct to laser or RF resurfacing treatments, both ablative and non-ablative
Complement to PRP or stem cell-based therapies
Management of inflammatory dermatoses under physician supervision
Advanced skin barrier restoration protocols
Support for medication-induced sensitivity and environmental damage recovery
By working in harmony with the skin’s natural repair mechanisms, Celexo Exo Cica supports consistent, high-quality results with reduced risks and improved patient satisfaction.
Ideal Use Environment
Celexo Exo Cica is not a consumer product and is intended exclusively for application by licensed professionals in medical or aesthetic clinical environments.
Recommended For Use By:
- Board-certified dermatologists
- Plastic and cosmetic surgeons
- Licensed medical spas with physician oversight
- Trained aesthetic practitioners
- Clinical research teams and biomedical institutions
Each formulation is manufactured under controlled conditions in Korea, adhering to rigorous standards for purity, safety, and consistency. Complete technical documentation is available to licensed professionals.
Why Choose ABio materials as Your Manufacturing Partner
ABio materials Co. stands apart through commitment to scientific innovation, clinical excellence, and precision manufacturing in aesthetic medicine. Each formulation, including Celexo Exo Cica, results from rigorous research conducted in collaboration with biomedical experts to ensure maximum safety, efficacy, and clinical relevance.
With Korean-based production facilities operating under strict regulatory oversight, including ISO 13485 certification and GMP compliance, the company guarantees consistent quality and reliable delivery. All products are US FDA-listed. Quality control includes nanoparticle tracking analysis for exosome verification, protein quantification for bioactive content, and microbiological testing per USP standards.
Dedicated exclusively to licensed professionals through ABio materials USA Inc. for North American distribution, the company delivers evidence-based biomaterials that elevate patient outcomes without compromising safety. Technical support is available for protocol development, integration guidance, and ongoing professional education.
Frequently Asked Questions
What is Celexo Exo Cica made of?
Celexo Exo Cica is a proprietary blend of plant-derived exosomes and Centella Asiatica bioactives developed to support barrier restoration and cellular activity. Full technical data is available to licensed professionals upon request.
Can patients purchase Celexo Exo Cica directly?
No. Celexo Exo Cica is not sold directly to consumers. It is intended solely for professional use in licensed medical or aesthetic environments.
How can providers obtain Celexo Exo Cica?
Clinics and licensed practitioners may contact ABio materials USA Inc., the exclusive North American distributor, via a-biousa.com to request information about clinical use, product availability, or distribution partnerships.
Is Celexo Exo Cica FDA-approved?
All ABio materials products are US FDA-listed and produced in pharmaceutical-grade facilities in Korea in accordance with applicable manufacturing standards. The product is not intended to diagnose, treat, or cure any medical condition.
Where is Celexo Exo Cica manufactured?
All production is conducted by ABio materials Co. in pharmaceutical-grade facilities in Korea under strict U.S. quality assurance and regulatory compliance protocols.
Leading the Future of Regenerative Aesthetics
As regenerative aesthetics continue to gain traction in clinical practice, ABio materials Co. stands out as a leader in developing safe, science-driven biomaterials. Celexo Exo Cica reflects this mission by offering a biologically intelligent, clinically effective solution for aesthetic professionals committed to enhancing patient outcomes.
To learn more about integrating Celexo Exo Cica into your practice or to explore collaboration opportunities, visit a-biousa.com.
Contact Us
We welcome inquiries from partners, distributors, and industry professionals worldwide. Whether you are interested in our product portfolio, ODM/OEM collaboration, or research support, our team is committed to providing clear, timely, and knowledgeable assistance. Reach out to learn how our bio-material technologies and exosome expertise can support your clinical, aesthetic, or research goals.
Get in touch
